The Long COVID-19 Wearable Device Study
To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.
| Condition(s) | Long COVID, Postural Orthostatic Tachycardia Syndrome, Dysautonomia, Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Long Covid19 |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise. |
| Who can participate | Inclusion Criteria: * Is at least 18 years old. * Has a self/and or physician diagnosis of: * Long COVID (based on the WHO working definition), * ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or * POTS (Postural Orthostatic Tachycardia Syndrome). * Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms. * Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one. * Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly. * Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback. * Agrees to disclose involvement in other ME/CFS, POTS, and/or Lo |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Scripps Translational Science Institute |
| Locations | La Jolla, California, United States |
| Start date | 2023-11-16 |
| NCT ID | NCT05741112 |
| Official listing | https://clinicaltrials.gov/study/NCT05741112 |